Literature DB >> 7011347

Hepatitis associated with captopril treatment.

M Vandenburg, P Parfrey, P Wright, E Lazda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7011347      PMCID： PMC1401683          DOI： 10.1111/j.1365-2125.1981.tb01116.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  1 in total

Review 1.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321
  1 in total
  4 in total

1.  Cytolytic hepatitis with captopril but not with enalapril.

Authors:  F Zannad; P Y Marie; E Aliot; P Trechot; J M Gilgenkrantz
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

2.  Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment.

Authors:  A Zimran; A S Abraham; C Hershko
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 4.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.